159 related articles for article (PubMed ID: 17822370)
1. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.
Dayal S; Lentz SR
Antioxid Redox Signal; 2007 Nov; 9(11):1899-909. PubMed ID: 17822370
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
Wilson KM; Lentz SR
Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of homocysteine-induced atherothrombosis.
Lentz SR
J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
[TBL] [Abstract][Full Text] [Related]
4. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia and atherothrombotic disease.
de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
[TBL] [Abstract][Full Text] [Related]
6. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
Austin RC; Lentz SR; Werstuck GH
Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
van Guldener C; Stehouwer CD
Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of thrombosis in hyperhomocysteinemia.
Lentz SR
Curr Opin Hematol; 1998 Sep; 5(5):343-9. PubMed ID: 9776214
[TBL] [Abstract][Full Text] [Related]
9. Murine models of hyperhomocysteinemia and their vascular phenotypes.
Dayal S; Lentz SR
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1596-605. PubMed ID: 18556571
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.
Weiss N
Curr Drug Metab; 2005 Feb; 6(1):27-36. PubMed ID: 15720205
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
Weiss N; Keller C; Hoffmann U; Loscalzo J
Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocysteinemia and lower extremity wounds.
Schwartzfarb EM; Romanelli P
Int J Low Extrem Wounds; 2008 Sep; 7(3):126-36. PubMed ID: 18757388
[TBL] [Abstract][Full Text] [Related]
14. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
Papatheodorou L; Weiss N
Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
[TBL] [Abstract][Full Text] [Related]
15. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
16. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine-Induced Endothelial Dysfunction.
Lai WK; Kan MY
Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
[TBL] [Abstract][Full Text] [Related]
18. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
De Vriese AS; Blom HJ; Heil SG; Mortier S; Kluijtmans LA; Van de Voorde J; Lameire NH
Circulation; 2004 May; 109(19):2331-6. PubMed ID: 15117854
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.
Edirimanne VE; Woo CW; Siow YL; Pierce GN; Xie JY; O K
Can J Physiol Pharmacol; 2007 Dec; 85(12):1236-47. PubMed ID: 18066125
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of superoxide dismutase promotes cerebral vascular hypertrophy and vascular dysfunction in hyperhomocysteinemia.
Dayal S; Baumbach GL; Arning E; Bottiglieri T; Faraci FM; Lentz SR
PLoS One; 2017; 12(4):e0175732. PubMed ID: 28414812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
